Sorry, no definitions found. You may find more data at alcon's.


Sorry, no etymologies found.


  • Prisoners is set up as one of Alcon's latter releases this year through it's put deal with Warner, so I'm not sure Alcon is willing to forgo a third of it's potential revenue by waiting for Leo to make another picture.

    Leonardo Di Caprio Considering Prisoners; Commitment Depends On Who Directs | /Film

  • Revenue rose 18% to $14.84 billion from $12.58 billion a year earlier, helped by strong sales of new drugs for multiple sclerosis and other diseases, and by the inclusion of Alcon's results.

    Novartis Plans to Cut 2,000 Jobs

  • The U.S. health agency is investigating Alcon's marketing of several products, including surgical equipment and drugs for eye disease.

    Novartis Plans to Cut 2,000 Jobs

  • While Alcon's minority shareholders have so far balked at the offer, a higher Novartis share price could help stifle the current resistance, analysts say, adding that otherwise Novartis will have to lift its Alcon bid for the remaining 23% stake it doesn't own.

    Novartis's Net Profit Jumps 10%

  • The company hopes Alcon's improving profitability would help shield group sales and margins as Novartis faces generic competition to top-selling blood pressure pill Diovan.

    Novartis: Strategy on Track

  • In 2009, the Ministry of Commerce rejected Coca-Cola Co.'s $2.4 billion bid for China Huiyuan Juice Group Ltd. Last year, it approved Novartis AG's acquisition of Alcon Inc., but barred Novartis from selling one of its premerger contact-lens-care products in China for five years due to Alcon's dominant share of sales of those products there.

    Beijing Gains Clout on Deals

  • Novartis will be barred from selling one of its premerger ophthalmological anti-infection products in China for five years, due to Alcon's dominant market share in those products in the country.

    China Approves Novartis-Alcon Deal

  • Alcon's independent directors committee says according to the company's bylaws and Swiss law, those nominees aren't allowed to vote on issues regarding the proposed Novartis takeover because they are conflicted.

    Alcon Says Novartis Takeover Faces Legal Hurdle

  • Alcon's independent directors 'committee said according to Swiss law and company rules that Novartis's proposed takeover of Alcon will become legally effective only when five steps have been completed, which in addition to the two-thirds shareholder approval, include approval by the committee and confirmation by an independent auditor that the merger consideration is "justifiable" and the process for determining the exchange ratio was "appropriate."

    Alcon Says Novartis Takeover Faces Legal Hurdle

  • The fund was created because once Novartis becomes Alcon's majority shareholder, Novartis could make moves to try to withhold funding from the independent directors committee.

    Alcon Says Novartis Takeover Faces Legal Hurdle


Log in or sign up to get involved in the conversation. It's quick and easy.